BromSite Ophthalmic Solution Recalled for Lack of Sterility Assurance
Sun Pharmaceutical is recalling BromSite (bromfenac) 0.075% ophthalmic solution due to a lack of sterility assurance. The recall affects 69,840 bottles distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall involves a risk-of-harm product (lack of sterility assurance in an ophthalmic solution) where injury has not yet been reported, which aligns with the 'High' severity criteria for theoretical risks without confirmed illness.
Plain-English summary
Sun Pharmaceutical Industries, Inc. is recalling 69,840 bottles of BromSite (bromfenac ophthalmic solution) 0.075%, 5 mL bottles. The product is a prescription-only ophthalmic solution distributed nationwide within the United States. The specific lot number is V18E01 with an expiration date of 05/2020.
The recall was initiated because the product may have a lack of sterility assurance. Sterility is critical for ophthalmic solutions to prevent infection. The source text does not report any specific illnesses or injuries associated with this recall.
Consumers and healthcare providers should check their inventory for the specific lot number and expiration date listed above. If the product matches the recalled lot, it should be discontinued and returned to the distributor or disposed of according to local regulations. Patients should consult their healthcare provider for alternative treatments if necessary.
The recalled product
- Product
- BROMSITE (BROMFENAC)
- Brand
- BROMSITE
- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- Category
- Drug — Ophthalmic Solution
- Hazard
- Affected units
- 69,840
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: V18E01
- Exp. 05/2020
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Sun Pharmaceutical Industries, Inc.
See all →- HighSun Pharmaceutical Recalls Carbamazepine Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2026-08-26
- LowFexofenadine Hydrochloride Tablets 180 mg Recalled for Impurities
FDA (Drugs) · 2026-07-08
- HighPerampanel Prescription Tablets Recalled for Labeling Mix-up
FDA (Drugs) · 2026-07-01
- HighBudesonide inhalation ampules contain black and brown specks and particles
FDA (Drugs) · 2026-06-17
- SevereDoxorubicin liposome injection vials contain glass particulate matter
FDA (Drugs) · 2026-06-17
Same hazard · lack of sterility
See all →- HighRohto Cooling Eye Drops Max Strength Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighRohto Cooling Eye Drops Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2026-07-29
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-07-15
- SevereAzacitidine for Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15